Changes Over Time in Glycemic Control, Insulin Sensitivity, and β-Cell Function in Response to Low-Dose Metformin and Thiazolidinedione Combination Therapy in Patients With Impaired Glucose Tolerance

OBJECTIVE: In the Canadian Normoglycemia Outcome Evaluation (CANOE) trial, low-dose rosiglitazone/metformin reduced the risk of diabetes in subjects with impaired glucose tolerance by 66% over a median of 3.9 years. We evaluate the temporal changes in glycemic control, insulin sensitivity, and β-cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Retnakaran, Ravi, Qi, Ying, Harris, Stewart B., Hanley, Anthony J., Zinman, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120173/
https://www.ncbi.nlm.nih.gov/pubmed/21709296
http://dx.doi.org/10.2337/dc11-0046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120173/
https://www.ncbi.nlm.nih.gov/pubmed/21709296
http://dx.doi.org/10.2337/dc11-0046

Ejemplares similares